The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists
Open accessAbstract
Insulin resistance is a characteristic feature of most patients with type 2 diabetes mellitus and is almost a universal finding in type 2 diabetic patients who are overweight (1–3). The presence of insulin resistance leads to increased β-cell insulin secretion with compensatory hyperinsulinemia (1–3). As long as the hyperinsulinemia is adequate to overcome the insulin resistance, glucose tolerance remains normal. In patients destined to develop type 2 diabetes, the β-cell compensatory response declines, and relative, or absolute, insulin insufficiency develops. At this point, insulin secretion cannot keep pace with the underlying insulin resistance, and glucose intolerance and eventually frank type 2 diabetes occur. Based on these observations it is evident that, except for very unusual patients, type 2 diabetes only develops in the context of insulin resistance plus β cell dysfunction. Although there is still some debate as to whether the insulin resistance or the β-cell defect comes first, most epidemiologic studies have indicated that in the early, prediabetic state, insulin resistance is the antecedent abnormality (4, 5).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
Barak, Y., Nelson, M. C., Ong, E. S., Jones, Y. Z., Ruiz-Lozano, P., Chien, K. R., Koder, A., & Evans, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80209-9 · Cited by 1,956
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
Spiegelman, B. M. (1998) · Diabetes · doi:10.2337/diabetes.47.4.507 · Cited by 1,730
Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
Barroso, I., Gurnell, M., Crowley, V. E. F., Agostini, M., Schwabe, J. W., Soos, M. A., Maslen, G. L., Williams, T. D. M., Lewis, H., Schafer, A. J., et al. (1999) · Nature · doi:10.1038/47254 · Cited by 1,368
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,358
Deeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L., Kuusisto, J., Laakso, M., Fujimoto, W., & Auwerx, J. (1998) · Nature Genetics · doi:10.1038/3099 · Cited by 1,319
Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase
Nagy, L., Kao, H.-Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80218-4 · Cited by 1,230
Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes
Saltiel, A. R., & Olefsky, J. M. (1996) · Diabetes · doi:10.2337/diab.45.12.1661 · Cited by 1,053
Self-citationWarram, J. H., Martin, B. C., Krolewski, A. S., Soeldner, J. S., & Kahn, C. R. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-909 · Cited by 1,038
Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
Nolan, J. J., Ludvik, B., Beerdsen, P., Joyce, M., & Olefsky, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311803 · Cited by 926
Self-citationVidal-Puig, A. J., Considine, R. V., Jimenez-Liñan, M., Werman, A., Pories, W. J., Caro, J. F., & Flier, J. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119424 · Cited by 786
Zhu, Y., Qi, C., Korenberg, J. R., Chen, X. N., Noya, D., Rao, M. S., & Reddy, J. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7921 · Cited by 653
Fujiwara, T., Yoshioka, S., Yoshioka, T., Ushiyama, I., & Horikoshi, H. (1988) · Diabetes · doi:10.2337/diab.37.11.1549 · Cited by 473
Ehrmann, D. A., Schneider, D. J., Sobel, B. E., Cavaghan, M. K., Imperial, J., Rosenfield, R. L., & Polonsky, K. S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4069 · Cited by 461
Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM Subjects
Suter, S. L., Nolan, J. J., Wallace, P., Gumbiner, B., & Olefsky, J. M. (1992) · Diabetes Care · doi:10.2337/diacare.15.2.193 · Cited by 420
Self-citationImproved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency
Miles, P. D. G., Barak, Y., He, W., Evans, R. M., & Olefsky, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8538 · Cited by 400
Self-citationAn Essential Regulator of Adipogenesis and Modulator of Fat Cell Function: PPARγ
Lowell, B. B. (1999) · Cell · doi:10.1016/s0092-8674(00)81654-2 · Cited by 383
Tontonoz, P., Graves, R. A., Budavari, A. I., Erdjument-Bromage, H., Lui, M., Hu, E., Tempst, P., & Spiegelman, B. M. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.25.5628 · Cited by 383
Troglitazone action is independent of adipose tissue.
Burant, C. F., Sreenan, S., Hirano, K., Tai, T. A., Lohmiller, J., Lukens, J., Davidson, N. O., Ross, S., & Graves, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119839 · Cited by 334
Deconstructing Type 2 Diabetes
Taylor, S. I. (1999) · Cell · doi:10.1016/s0092-8674(00)80709-6 · Cited by 307
The Molecular Pharmacology of SERMs
McDonnell, D. P. (1999) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(99)00177-0 · Cited by 299
Maggs, D. G., Buchanan, T. A., Burant, C. F., Cline, G., Gumbiner, B., Hsueh, W. A., Inzucchi, S., Kelley, D., Nolan, J., Olefsky, J. M., et al. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-3-199802010-00002 · Cited by 286
Self-citationInsights into insulin resistance and type 2 diabetes from knockout mouse models
Kadowaki, T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10830 · Cited by 249
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients
The Troglitazone study group, Kumar, S., Boulton, A. J. M., Beck-Nielsen, H., Berthezene, F., Muggeo, M., Persson, B., Spinas, G. A., Donoghue, S., Lettis, S., et al. (1996) · Diabetologia · doi:10.1007/bf00418542 · Cited by 236
Camp, H. S., Li, O., Wise, S. C., Hong, Y. H., Frankowski, C. L., Shen, X., Vanbogelen, R., & Leff, T. (2000) · Diabetes · doi:10.2337/diabetes.49.4.539 · Cited by 224
Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat
Lee, M. K., Miles, P. D., Khoursheed, M., Gao, K. M., Moossa, A. R., & Olefsky, J. M. (1994) · Diabetes · doi:10.2337/diabetes.43.12.1435 · Cited by 194
Self-citationIwamoto, Y., Kuzuya, T., Matsuda, A., Awata, T., Kumakura, S., Inooka, G., & Shiraishi, I. (1991) · Diabetes Care · doi:10.2337/diacare.14.11.1083 · Cited by 193
Kruszynska, Y. T., Yu, J. G., Olefsky, J. M., & Sobel, B. E. (2000) · Diabetes · doi:10.2337/diabetes.49.4.633 · Cited by 185
Self-citationTNF-α-Induced Insulin Resistance In Vivo and Its Prevention by Troglitazone
Miles, P. D. G., Romeo, O. M., Higo, K., Cohen, A., Rafaat, K., & Olefsky, J. M. (1997) · Diabetes · doi:10.2337/diab.46.11.1678 · Cited by 183
Self-citationIn vitro studies on the action of CS-045, a new antidiabetic agent
Ciaraldi, T. P., Gilmore, A., Olefsky, J. M., Goldberg, M., & Heidenreich, K. A. (1990) · Metabolism · doi:10.1016/0026-0495(90)90166-a · Cited by 164
Self-citationPro12Ala Missense Mutation of the Peroxisome Proliferator Activated Receptor γ and Diabetes Mellitus
Ringel, J., Engeli, S., Distler, A., & Sharma, A. M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9962 · Cited by 152
Metabolic Effects of Troglitazone on Fructose-Induced Insulin Resistance in the Rat
Lee, M.-K., Miles, P. D. G., Khoursheed, M., Gao, K., Moossa, A. R., & Olefsky, J. M. (1994) · Diabetes · doi:10.2337/diab.43.12.1435 · Cited by 141
Self-citationIbrahimi, A., Teboul, L., Gaillard, D., Amri, E., Ailhaud, G. P., Young, P. W., Cawthorne, M. A., & Grimaldi, P. A. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09853-0 · Cited by 137
Mori, Y., Kim-Motoyama, H., Katakura, T., Yasuda, K., Kadowaki, H., Beamer, B. A., Shuldiner, A. R., Akanuma, Y., Yazaki, Y., & Kadowaki, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9421 · Cited by 133
Fujiwara, T., Wada, M., Fukuda, K., Fukami, M., Yoshioka, S., Yoshioka, T., & Horikoshi, H. (1991) · Metabolism · doi:10.1016/0026-0495(91)90218-l · Cited by 115
Berkowitz, K. M., Peters, R., Kjos, S. L., Goico, J., Marroquin, A., Dunn, M. E., Xiang, A. H., Azen, S. P., & Buchanan, T. A. (1996) · Diabetes · doi:10.2337/diab.45.11.1572 · Cited by 108
Kruszynska, Y. T., Mukherjee, R., Jow, L., Dana, S. L., Paterniti, J. R., & Olefsky, J. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1076 · Cited by 82
Self-citationKraegen, E. W., James, D. E., Jenkins, A. B., Chisholm, D. J., & Storlien, L. H. (1989) · Metabolism · doi:10.1016/0026-0495(89)90045-0 · Cited by 55
Acute effects of troglitazone on in vivo insulin action in normal rats
Lee, M.-K., & Olefsky, J. M. (1995) · Metabolism · doi:10.1016/0026-0495(95)90010-1 · Cited by 54
Self-citationSironi, A. M., Vichi, S., Gastaldelli, A., Pecori, N., Anichini, R., FOOT, E. A., Seghieri, G., & Ferrannini, E. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90068-0 · Cited by 52
Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
Miles, P. D. G., Higo, K., Romeo, O. M., Lee, M. K., Rafaat, K., & Olefsky, J. M. (1998) · Diabetes · doi:10.2337/diabetes.47.3.395 · Cited by 45
Self-citationAcute troglitazone action in isolated perfused rat liver
Preininger, K., Stingl, H., Englisch, R., Fürnsinn, C., Graf, J., Waldhäusl, W. K., & Roden, M. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702318 · Cited by 45
Cited by
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Type 2 diabetes: principles of pathogenesis and therapy
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662
Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2094 · Cited by 1,659
Pajvani, U. B., Hawkins, M., Combs, T. P., Rajala, M. W., Doebber, T., Berger, J. P., Wagner, J. A., Wu, M., Knopps, A., Xiang, A. H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311113200 · Cited by 1,163
Self-citationDiabetes and mitochondrial function: Role of hyperglycemia and oxidative stress
Rolo, A. P., & Palmeira, C. M. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.01.003 · Cited by 1,007
“In this respect, PPARγ appears to be of promising pharmacological interest since it was identified as the target of TZDs used in the treatment of non-insulin-dependent diabetes mellitus (Olefsky, 2000; Ram, 2003).”
Background
Metadata
- Authors
- Olefsky, J. M.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-08-15
- Volume
- 106
- Issue
- 4
- Pages
- 467-472
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1983128420
- Cited by
- 537
- References
- 48
- FWCI
- 13.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.